Peter Lynch · Growth at a reasonable price (GARP)
Is Medpace Holdings, Inc. (MEDP) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
65/100
Mixed
6/6 criteria passed
Peter Lynch's Criteria, Applied to MEDP
PEG ≤ 1.0
key0.79
EPS CAGR ≥ 15%
key32.6%
Revenue CAGR ≥ 10%
22.0%
Net margin > 0
17.2%
How MEDP Scores on Other Strategies
Live Financial Snapshot
Market cap
$18.95B
P/E (TTM)
25.7x
ROIC (TTM)
56.06%
Gross margin
29.07%
Other Peter Lynch fit reports
Frequently Asked Questions
What is MEDP's Peter Lynch fit score?
MEDP scores 65/100 on our Peter Lynch fit engine. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own MEDP?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends MEDP.
How often is this score updated?
MEDP's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends MEDP.
